AONC Insider Trading Activity and SEC Form 4 Filings
AONC insider trading summary
No open-market insider purchases or sales of American Oncology Network, Inc. (AONC) have been reported on SEC Form 4 in the past 12 months.
Latest AONC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 24, 2024 | Stephen Divers | Chief Medical Officer | Buy | $11K (5,000 @ $2.15) |
| May 21, 2024 | Todd Schonherz | Chief Executive Officer | Buy | $2K (1,000 @ $1.85) |
| May 21, 2024 | Todd Schonherz | Chief Executive Officer | Buy | $632 (340 @ $1.86) |
| May 21, 2024 | Todd Schonherz | Chief Executive Officer | Buy | $7K (4,000 @ $1.87) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.